AstraZeneca reports first-half growth, disappointment in Ultomiris trial
AstraZeneca reported first-half total revenue of $30.7bn on Monday, up 9%, while core earnings per share increased 12%…
Are Britain’s biscuit breaks disappearing? McVitie’s warns of ‘always-on’ culture
Key takeaways: McVitie’s research found nearly half of UK consumers feel guilty about taking breaks during the day,…